Edwards’ 3Q Prelim Sales Disappoint – Analyst Blog

By | October 9, 2012
0 Comment

Edwards Lifesciences ( EW ) reported disappointing third quarter 2012 results. The company expects to report $448 million in sales (representing year-over-year growth of 9% or 14% at

More here:
Edwards’ 3Q Prelim Sales Disappoint – Analyst Blog

Related posts:

  1. Edwards Lifesciences (EW) – Bear of the Day
  2. Edwards’ 2013 Guidance Encourages – Analyst Blog
  3. Smith & Wesson 2Q Prelim Favorable – Analyst Blog
  4. Australia: November Retail Sales disappoint at -0.1%